Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

Blog

Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.

Loading...

Rapid blood test offers new hope for people most at risk of TB

July 10, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is thought to carry latent TB, it carries a risk of progressing to the active form of TB in around 10%...

Rapid blood test offers new hope for people most at risk of TB

July 10, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is...

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is thought to carry latent TB, it only progresses to active disease in around 10% of those infected. The reasons for...

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is...
Berwyn Clarke

PBD Biotech CEO announces his retirement

April 18, 2019
After growing PBD Biotech from start-up to international player in just three years, Dr Berwyn Clarke has decided to retire as CEO to make time for other business interests. He will remain on the diagnostics company’s Board of Directors.
Berwyn Clarke

PBD Biotech CEO announces his retirement

April 18, 2019
After growing PBD Biotech from start-up to international player in just three years, Dr Berwyn Clarke has decided to retire...
Blood test

New Actiphage test enters human TB trials

March 6, 2019
A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage of infection.
Blood test

New Actiphage test enters human TB trials

March 6, 2019
A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage...
Bacteria

PBD Biotech secures grant of key patent for new bacterial diagnostic technology

October 25, 2018
PBD Biotech Limited is pleased to announce that its key technology patent has been granted by the European Patent Office.
Bacteria

PBD Biotech secures grant of key patent for new bacterial diagnostic technology

October 25, 2018
PBD Biotech Limited is pleased to announce that its key technology patent has been granted by the European Patent Office.
Dr Berwyn Clarke at REAP

‘Angel investors bring more than money’ – Interview with PBD Biotech CEO

August 7, 2018
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for entrepreneurs, about the start-up’s strategic approach to securing the right investment for phage-based technology.
Dr Berwyn Clarke at REAP

‘Angel investors bring more than money’ – Interview with PBD Biotech CEO

August 7, 2018
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for...

PBD Biotech closes seed investment round

August 24, 2017
PBD Biotech Ltd is delighted to announce that it has successfully completed an over-subscribed seed investment round composed of angel investment from Cambridge Agritech Ltd and Anglia Capital Group.

PBD Biotech closes seed investment round

August 24, 2017
PBD Biotech Ltd is delighted to announce that it has successfully completed an over-subscribed seed investment round composed of angel...
PBD Biotech - blood tests

Exploiting phage to detect Mycobacteria – things you discover when you don’t know not to look

July 26, 2016
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
PBD Biotech - blood tests

Exploiting phage to detect Mycobacteria – things you discover when you don’t know not to look

July 26, 2016
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
Virulence paper feat

Evidence of mycobacterium tuberculosis complex bacteraemia

May 19, 2016
A research paper has been published in Virulence journal, by Benjamin Swift, Thomas Convery and Catherine Rees: 'Evidence of Mycobacterium tuberculosis complex bacteraemia in intradermal skin test positive cattle detected using phage-RPA'.
Virulence paper feat

Evidence of mycobacterium tuberculosis complex bacteraemia

May 19, 2016
A research paper has been published in Virulence journal, by Benjamin Swift, Thomas Convery and Catherine Rees: 'Evidence of Mycobacterium...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us
BIVDA member 2023

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!